Association of Sialic Acid–Binding Immunoglobulin-Like Lectin 15 With Phenotypes in Esophageal Squamous Cell Carcinoma in the Setting of Neoadjuvant Chemoradiotherapy

西格莱克 医学 肿瘤科 内科学 队列 新辅助治疗 唾液酸 免疫组织化学 免疫系统 放化疗 免疫学 癌症 生物 乳腺癌 遗传学
作者
Sha Zhou,Yuting Wang,Rui Zhang,Weian Zeng,Shiliang Liu,Songran Liu,Mengzhong Liu,Hong Yang,Mian Xi
出处
期刊:JAMA network open [American Medical Association]
卷期号:6 (1): e2250965-e2250965 被引量:7
标识
DOI:10.1001/jamanetworkopen.2022.50965
摘要

Importance Sialic acid–binding immunoglobulin-like lectin 15 (Siglec-15) is a novel immune checkpoint molecule that is highly homologous to programmed cell death ligand 1 (PD-L1), but information remains limited about its role in esophageal squamous cell carcinoma (ESCC). Objective To explore the expression pattern and association of Siglec-15 with outcomes among patients with ESCC who received neoadjuvant chemoradiotherapy (CRT). Design, Setting, and Participants This retrospective cohort study was conducted at an academic institution in China. Participants included patients with ESCC who underwent neoadjuvant CRT and esophagectomy between June 2002 and December 2018. Multiplexed immunofluorescence staining was used to evaluate the expression of Siglec-15 and PD-L1 in tumor cells (TCs) or tumor-associated macrophages based on pre-CRT biopsies. Different immune phenotypes have been proposed and further validated in an independent cohort. Data analysis was conducted from January to May 2021. Exposures Siglec-15 or PD-L1 positivity vs negativity. Main Outcomes and Measures Pathologic complete response (pCR), overall survival (OS), and recurrence-free survival (RFS). Results Of 130 participants (median [range] age, 56 [42-73] years; 108 [83.1%] male participants) in the primary cohort, 58 patients (44.6%) achieved a pCR after neoadjuvant CRT. Siglec-15 and PD-L1 were detected in both TCs and macrophages. The percentage of Siglec-15–positive macrophages was notably higher than that of Siglec-15–positive TCs (median [IQR]: 34.4% [12.7%-64.3%] vs 4.8% [0.7%-25.6%]; P < .001). TC–Siglec-15 expression was significantly and positively associated with macrophage–Siglec-15 expression ( r = 0.78; P < .001). Siglec-15 positivity was significantly associated with a higher rate of pCR (37 of 70 [52.9%] vs 21 of 60 [35.0%]; P = .04), more favorable OS (hazard ratio [HR], 0.46; 95% CI, 0.25-0.85; P = .01), and RFS (HR, 0.48; 95% CI, 0.26–0.88; P = .02). However, PD-L1 positivity in TCs was negatively associated with survival. Stratification analysis further revealed that patients with combined Siglec-15 positivity and PD-L1 negativity had better survival than those with other phenotypes. Major findings were reproducible in a validation cohort with 55 patients. Conclusions and Relevance In this cohort study of patients with ESCC receiving neoadjuvant CRT, Siglec-15 positivity was associated with a better pathological response and more favorable survival. Siglec-15 could serve as a novel biomarker to identify potential candidates that may benefit from immunotherapy combined with CRT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
phhhhh发布了新的文献求助10
1秒前
zhouti497541171完成签到,获得积分10
1秒前
轻松幼荷完成签到,获得积分10
1秒前
滴滴发布了新的文献求助10
1秒前
隐形煎蛋完成签到,获得积分10
1秒前
牧青发布了新的文献求助10
2秒前
向晚彭彭完成签到 ,获得积分10
2秒前
天天快乐的应助被LITM采纳,获得10
2秒前
淘气宇发布了新的文献求助10
3秒前
石家庄铁道完成签到,获得积分10
4秒前
hhh完成签到,获得积分10
4秒前
4秒前
4秒前
111发布了新的文献求助10
6秒前
7秒前
呼呀呼发布了新的文献求助10
7秒前
7秒前
腼腆的发箍完成签到,获得积分10
8秒前
8秒前
8秒前
共享精神的应助被sweetxj采纳,获得10
9秒前
思源的应助被renguagua采纳,获得10
9秒前
123发布了新的文献求助10
9秒前
爱听歌的依霜完成签到,获得积分10
9秒前
LITM完成签到,获得积分10
10秒前
10秒前
11秒前
执着的青烟完成签到,获得积分10
11秒前
霍霍发顶刊完成签到 ,获得积分10
12秒前
周灿发布了新的文献求助10
12秒前
yy发布了新的文献求助10
12秒前
大气的衣发布了新的文献求助10
12秒前
丘比特的应助被mudiboyang采纳,获得10
13秒前
调皮无招发布了新的文献求助200
13秒前
kali发布了新的文献求助10
14秒前
14秒前
王博林发布了新的文献求助30
14秒前
15秒前
XIAO完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191812
求助须知:如何正确求助?哪些是违规求助? 9578503
关于积分的说明 21859856
捐赠科研通 7791184
什么是DOI,文献DOI怎么找? 3436733
关于科研通互助平台的介绍 2560447
邀请新用户注册赠送积分活动 2483502